EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular Prevalence and Risk Factors of Hepatitis B Virus Infection Among the Patients Attending the Human Medical Laboratories in Kabul, Afghanistan

Muhammad Farooq Haider, Bilal Ahmad Rahimi, Zargul Shinwary, Mehmood Shah Rahimi, Haider Ali Malakzai

Afghanistan Journal of Infectious Diseases · 2026

DOI: 10.60141/ajid.123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Afghanistan Journal of Infectious Diseases, 2026. Verfasst von Muhammad Farooq Haider und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatitis B virus (HBV) can cause acute and/or chronic hepatitis, responsible for over one million deaths annually. We aimed to estimate the prevalence of hepatitis B and its risk factors among the patients attending the Human Medical Laboratories (HML) in Kabul, Afghanistan.

Methods

This retrospective study was conducted on samples received between January 2022 and September 2023. We tested 2062 blood samples using a Geneproof Amplification Kit and Rotor-Gene Real-Time PCR. Descriptive and analytical statistics (Chi-square test and logistic regression) were analyzed using SPSS version 26.

Results

The prevalence of HBV was 51.2% (1056/2062), with 59.3% males and a mean (SD) age of 32.0 (14.9) years. The majority of the HBV-positive patients (792/1056 or 74.8%) were from the age group of 16–45 years. The highest and lowest prevalence of HBV was observed in Kandahar (29/48 or 60.4%) and Nangarhar (107/235 or 45.5%), respectively. The mean overall HBV viral load was 39,587,427.2 IU/mL, with the highest and lowest mean viral load observed in patients from Takhar (71,940,575.8 IU/mL) and Kandahar (1,419,819.0 IU/mL), respectively. The statistically significant risk factors associated with HBV were blood transfusion, dental extraction, and syringe sharing.

Conclusion

HBV is highly prevalent among the Afghans attending HML in Kabul, Afghanistan. The Afghanistan Ministry of Public Health and international donor agencies should help in conducting more studies of HBV in all 34 provinces of Afghanistan. This will help in finding the real burden and risk factors of HBV in different regions and ethnicities of Afghanistan.

Zitieren

APA

Haider, M. F., Rahimi, B. A., Shinwary, Z., Rahimi, M. S., & Malakzai, H. A. (2026). Molecular Prevalence and Risk Factors of Hepatitis B Virus Infection Among the Patients Attending the Human Medical Laboratories in Kabul, Afghanistan. Afghanistan Journal of Infectious Diseases. https://doi.org/10.60141/ajid.123

Vancouver

Haider MF, Rahimi BA, Shinwary Z, Rahimi MS, Malakzai HA. Molecular Prevalence and Risk Factors of Hepatitis B Virus Infection Among the Patients Attending the Human Medical Laboratories in Kabul, Afghanistan. Afghanistan Journal of Infectious Diseases. 2026. doi:10.60141/ajid.123

BibTeX
@article{Haider2026,
  author = {Haider, Muhammad Farooq and Rahimi, Bilal Ahmad and Shinwary, Zargul and Rahimi, Mehmood Shah and Malakzai, Haider Ali},
  title = {Molecular Prevalence and Risk Factors of Hepatitis B Virus Infection Among the Patients Attending the Human Medical Laboratories in Kabul, Afghanistan},
  journal = {Afghanistan Journal of Infectious Diseases},
  year = {2026},
  doi = {10.60141/ajid.123}
}
Kostenlos starten →